Veterinary medicine lags decades behind humans. Our own experience with this gap is what motivates us to close it.

Kedi Bioscience is advancing the veterinary application of biologic therapeutics such as peptides and antibodies. These therapies revolutionised the care of challenging human diseases and are poised to do the same for animals.

Kedi’s platform technology discovers biologic therapies specifically tailored to cats. Our fully feline drug candidates replicate the mechanisms of human-approved therapies.

We utilise experimental and data sciences to develop a pipeline of innovative compounds and offer affordable therapies against acute and chronic conditions in cats.